Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma-Reference-Cited by-同舟云学术

Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma

Published:2017-10-12 Issue:2 Volume:59 Page:216-222
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Ghai Anchal,Maji Dolonchampa,Cho Nicholas,Chanswangphuwana Chantiya,Rettig Michael,Shen Duanwen,DiPersio John,Akers Walter,Dehdashti Farrokh,Achilefu Samuel,Vij Ravi,Shokeen Monica

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference34 articles.

1. Multiple myeloma: evolving genetic events and host interactions

2. Molecular pathogenesis of multiple myeloma and its premalignant precursor

3. Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

4. Improved survival in multiple myeloma and the impact of novel therapies

5. Antibody-based therapies in multiple myeloma;Tai;Bone Marrow Res.,2011

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-11

2. Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments;Critical Reviews in Oncology/Hematology;2024-09

3. Development of New CD38 Targeted Peptides for Cancer Imaging;Molecular Imaging and Biology;2024-03-13

4. CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET;Advanced Science;2024-02-29

5. Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library;Clinical Cancer Research;2024-01-26